BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3679
-0.0245 (-6.24%)
Aug 14, 2025, 11:50 AM - Market open

BioAtla Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-59.52-69.78-123.46-106.48-95.4-35.85
Upgrade
Depreciation & Amortization
0.750.931.221.21.331.01
Upgrade
Loss (Gain) From Sale of Assets
--00.010-
Upgrade
Stock-Based Compensation
7.158.9213.5414.5625.123.02
Upgrade
Other Operating Activities
-2.39-0.81---0.69-1.15
Upgrade
Change in Accounts Payable
-0-13.465.283.417.99-1.66
Upgrade
Change in Unearned Revenue
------0.43
Upgrade
Change in Other Net Operating Assets
1.682.26-0.6-3.12-0.57-1.27
Upgrade
Operating Cash Flow
-52.32-71.94-104.02-90.42-62.21-36.33
Upgrade
Capital Expenditures
---0.1-0.27-0.92-0.59
Upgrade
Sale of Property, Plant & Equipment
---0--
Upgrade
Investing Cash Flow
---0.1-0.27-0.92-0.59
Upgrade
Long-Term Debt Issued
-----3.43
Upgrade
Net Debt Issued (Repaid)
-----3.43
Upgrade
Issuance of Common Stock
9.369.560.3461.9771.42200.23
Upgrade
Repurchase of Common Stock
-0.05-0.05-0.26-0.76--
Upgrade
Other Financing Activities
-0.44----1.91-4.34
Upgrade
Financing Cash Flow
8.879.510.0861.2169.51271.83
Upgrade
Net Cash Flow
-43.46-62.43-104.04-29.476.37234.9
Upgrade
Free Cash Flow
-52.32-71.94-104.11-90.69-63.14-36.92
Upgrade
Free Cash Flow Margin
-475.66%-653.96%---25255.20%-8606.99%
Upgrade
Free Cash Flow Per Share
-0.97-1.48-2.18-2.33-1.83-4.38
Upgrade
Levered Free Cash Flow
-29.19-46.64-61.29-51.52-48.83-9.12
Upgrade
Unlevered Free Cash Flow
-29.19-46.64-61.29-51.52-48.83-8.25
Upgrade
Change in Working Capital
1.68-11.24.680.297.42-3.36
Upgrade
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q